Maze Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 28, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	2,086	-	-	-
Enterprise Value	1,727	-	-	-
Debt / Equity Ratio	0.06	0.14	4.94	0.32
Debt / EBITDA Ratio	-	0.40	-	-
Debt / FCF Ratio	-	0.36	-	-
Asset Turnover	-	1.07	-	-
Quick Ratio	17.40	9.52	1.79	4.81
Current Ratio	17.70	9.76	2.09	5.11
Return on Equity (ROE)	-52.69%	50.48%	-180.12%	-
Return on Assets (ROA)	-27.37%	23.07%	-55.63%	-
Return on Invested Capital (ROIC)	-634.89%	196.80%	-307.50%	-330.64%
Return on Capital Employed (ROCE)	-33.60%	26.20%	-178.60%	-86.00%
Buyback Yield / Dilution	-1176.31%	-19.33%	-13.82%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q